Physicians with current and valid licenses in the United States, Canada,
or Mexico who read any 3 of the selected continuing medical education (CME)
articles in this issue of JAMA, complete the CME Evaluation Form, and fax
it to the number or mail it to the address at the bottom of the CME Evaluation
Form are eligible for category 1 CME credit. There is no charge.
The American Medical Association (AMA) is accredited by the Accreditation
Council for Continuing Medical Education to sponsor CME for physicians. The
AMA designates this educational activity for up to 1 hour of category 1 CME
credit per JAMA issue toward the AMA Physician's Recognition Award (PRA).
Each physician should claim for credit only those hours that were actually
spent in this educational activity.
Physicians with current and valid licenses in the United States, Mexico,
or Canada are eligible for CME credit even if they live or practice in other
countries. Physicians licensed in other countries are also welcome to participate
in this CME activity. However, the PRA is available only to physicians licensed
in the United States, Canada, or Mexico.
To earn credit, read 3 of the articles listed below that are designated
for CME credit carefully and complete the CME Evaluation Form. The CME Evaluation
Form must be submitted within 1 month of the issue date. A certificate awarding
1 hour of category 1 CME credit will be faxed or mailed to you; it is then
your responsibility to maintain a record of credit received.
One of our goals is to assess continually the educational needs of our
readers so we may enhance the educational effectiveness of JAMA. To achieve
this goal, we need your help. You must complete the CME Evaluation Form to
JAMA is a general medical journal. Its mission and educational purpose
is to promote the science and art of medicine and the betterment of the public
health. A flexible curriculum of article topics is developed annually by THE
JOURNAL's editorial board and is then supplemented throughout the year with
information gained from readers, authors, reviewers, and editors. To accommodate
the diversity of practice types within JAMA's readership, the Reader's Choice
CME activity allows readers, as adult learners, to determine their own educational
needs and to assist the editors in addressing their needs in future issues.
Readers of JAMA should be able to attain the following educational
objectives: (1) select and read at least 3 articles in 1 issue to gain new
medical information on topics of particular interest to them as physicians,
(2) assess the articles' value to them as practicing physicians, and (3) think
carefully about how this new information may influence their own practices.
The educational objective for each CME article is given after the article
The following articles in this issue may be read for CME credit:
Raloxifene and Cardiovascular Events in Osteoporotic
Postmenopausal Women: Four-Year Results From the MORE (Multiple Outcomes of
Raloxifene Evaluation) Randomized TrialArticle
Educational Objective: To learn that a selective
estrogen receptor modulator may reduce the risk of cardiovascular events for
women at increased cardiovascular risk.
Fatal Inhalational Anthrax With Unknown Source of
Exposure in a 61-Year-Old Woman in New York CityArticle
Educational Objective: To learn about a case
of inhalational anthrax without a known source of exposure.
Fatal Inhalational Anthrax in a 94-Year-Old Connecticut
Educational Objective: To learn about the clinical
features and diagnostic difficulties of a case of inhalational anthrax.
Cutaneous Anthrax Associated With Microangiopathic
Hemolytic Anemia and Coagulopathy in a 7-Month-Old InfantArticle
Educational Objective: To compare the clinical
manifestations of cutaneous anthrax and spider toxin disease.
Secondary and Tertiary Palliative Care in US HospitalsArticle
Educational Objective: To understand the use
of palliative care services in hospitals and health systems.
β-Blocker Therapy in Heart Failure: Scientific
Educational Objective: To review the use of β-blocker
drugs for heart failure.
β-Blockers in Heart Failure: Clinical ApplicationsArticle
Educational Objective: To understand which
patients with heart failure may benefit most from β-blocker therapy.
After reading 3 of these articles, complete the CME Evaluation Form.
February 20, 2002. JAMA. 2002;287(7):921-922. doi:10.1001/jama.287.7.921